Synergistic induction of centrosome hyperamplification by loss of p53 and cyclin E overexpression

被引:119
作者
Mussman, JG
Horn, HF
Carroll, PE
Okuda, M
Tarapore, P
Donehower, LA
Fukasawa, K
机构
[1] Univ Cincinnati, Coll Med, Dept Cell Biol, Cincinnati, OH 45267 USA
[2] Baylor Coll Med, Div Mol Virol, Houston, TX 77030 USA
关键词
centrosome hyperamplification; cancer; p53; Cdk2; cyclin E;
D O I
10.1038/sj.onc.1203460
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Centrosome hyperamplification and the consequential mitotic defects contribute to chromosome instability in cancers. Loss or mutational inactivation of p53 has been shown to induce chromosome instability through centrosome hyperamplification. It has recently been found that Cdk2-cyclin E is involved in the initiation of centrosome duplication, and that constitutive activation of Cdk2-cyclin E results in the uncoupling of the centrosome duplication cycle and the DNA replication cycle. Cyclin E overexpression and p53 mutations occur frequently in tumors. Here, we show that cyclin E overexpression and loss of p53 synergistically increase the frequency of centrosome hyperamplification in cultured cells as well as in tumors developed in p53-null, heterozygous, and wildtype mice, Through examination of cells derived from Waf1-null mice, we further found that Waf1, a potent inhibitor of Cdk2-cyclin E and a major target of p53's transactivation function, is involved in coordinating the initiation of centrosome duplication and DNA replication, suggesting that Waf1 may act as a molecular link between p53 and Cdk2-cyclin E in the control of the centrosome duplication cycle.
引用
收藏
页码:1635 / 1646
页数:12
相关论文
共 75 条
  • [1] [Anonymous], MITOSIS MOL MECH
  • [2] Bornens Michel, 1992, P1
  • [3] MICROTUBULE ORGANIZING CENTERS
    BRINKLEY, BR
    [J]. ANNUAL REVIEW OF CELL BIOLOGY, 1985, 1 : 145 - 172
  • [4] CARBONAROHALL D, 1993, ONCOGENE, V9, P71
  • [5] Centrosome hyperamplification in human cancer: chromosome instability induced by p53 mutation and/or Mdm2 overexpression
    Carroll, PE
    Okuda, M
    Horn, HF
    Biddinger, P
    Stambrook, PJ
    Gleich, LL
    Li, YQ
    Tarapore, P
    Fukasawa, K
    [J]. ONCOGENE, 1999, 18 (11) : 1935 - 1944
  • [6] The p21Cip1 and p27Kip1 CDK 'inhibitors' are essential activators of cyclin D-dependent kinases in murine fibroblasts
    Cheng, MG
    Olivier, P
    Diehl, JA
    Fero, M
    Roussel, MF
    Roberts, JM
    Sherr, CJ
    [J]. EMBO JOURNAL, 1999, 18 (06) : 1571 - 1583
  • [7] MICE LACKING P21(C/P1/WAF1) UNDERGO NORMAL DEVELOPMENT, BUT ARE DEFECTIVE IN G1 CHECKPOINT CONTROL
    DENG, CX
    ZHANG, PM
    HARPER, JW
    ELLEDGE, SJ
    LEDER, P
    [J]. CELL, 1995, 82 (04) : 675 - 684
  • [8] ASSOCIATION OF HUMAN CYCLIN-E WITH A PERIODIC G(1)-S PHASE PROTEIN-KINASE
    DULIC, V
    LEES, E
    REED, SI
    [J]. SCIENCE, 1992, 257 (5078) : 1958 - 1961
  • [9] WAF1, A POTENTIAL MEDIATOR OF P53 TUMOR SUPPRESSION
    ELDEIRY, WS
    TOKINO, T
    VELCULESCU, VE
    LEVY, DB
    PARSONS, R
    TRENT, JM
    LIN, D
    MERCER, WE
    KINZLER, KW
    VOGELSTEIN, B
    [J]. CELL, 1993, 75 (04) : 817 - 825
  • [10] Synergy between the Mos/mitogen-activated protein kinase pathway and loss of p53 function in transformation and chromosome instability
    Fukasawa, K
    VandeWoude, GF
    [J]. MOLECULAR AND CELLULAR BIOLOGY, 1997, 17 (01) : 506 - 518